InsidersTradesSigma
Track the 엔솔바이오사이언스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엔솔바이오사이언스 has published 7 insider filings. Market capitalisation: €158.9bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 형인우. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Ensol Bioscience 是一家专注于健康和制药领域的公司，在XKRX市场上市。它致力于开发创新的生物制药解决方案。